Trinucleotide Repeats and Protein Folding and Disease: the Perspective From Studies With the Androgen Receptor

References

• Smith LB , MitchellRT, McEwanIJ. Testosterone: from Basic Research to Clinical Applications. Springer, NY, USA, (2013).
   Google Scholar
• He B , KemppainenJA, VoegelJJ, GronemeyerH, WilsonEM. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. J. Biol. Chem.274(52), 37219–37225 (1999).
   PubMed Web of Science ®Google Scholar
• Prescott J , CoetzeeGA. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett.231(1), 12–19 (2006).
   PubMed Web of Science ®Google Scholar
• Kumar R MI . Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr. Rev.33(2), 271–299 (2012).
   PubMed Web of Science ®Google Scholar
• Farla P , HersmusR, GevertsBet al. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. J. Struct. Biol.147(1), 50–61 (2004).
   PubMed Web of Science ®Google Scholar
• McEwan IJ . Intrinsic disorder in the androgen receptor: identification, characterisation and drugability. Mol. Biosyst.8(1), 82–90 (2012).
   PubMedGoogle Scholar
• Jordan CL , LiebermanAP. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?Curr. Opin. Pharmacol.8(6), 752–758 (2008).
   PubMed Web of Science ®Google Scholar
• La Spada AR , WilsonEM, LubahnDB, HardingAE, FischbeckKH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature352(6330), 77–79 (1991).
   PubMed Web of Science ®Google Scholar
• Fumiaki T , MasahisaK, HaruhikoB, KeisukeS, HiroakiA, GenS. Current status of treatment of spinal and bulbar muscular atrophy. Neural Plasticity2012369284 (2012).
   PubMed Web of Science ®Google Scholar
• Ackerman CM , LoweLP, LeeHet al. Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat. J. Androl.33(2), 210–215 (2012).
   PubMedGoogle Scholar
• Gelmann EP . Molecular biology of the androgen receptor. J. Clin. Oncol.20(13), 3001–3015 (2002).
   PubMed Web of Science ®Google Scholar
• Palazzolo I , GliozziA, RusminiPet al. The role of the polyglutamine tract in androgen receptor. J. Steroid Biochem. Mol. Biol.108(3–5), 245–253 (2008).
   PubMed Web of Science ®Google Scholar
• Castro-Nallar E , BacallaoK, Parada-BustamanteAet al. Androgen receptor gene CAG and GGN repeat polymorphisms in chilean men with primary severe spermatogenic failure. J. Androl.31(6), 552–559 (2010).
   PubMedGoogle Scholar
• Lundin KB , GiwercmanA, DizeyiN, GiwercmanYL. Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol. Cell. Endocrinol.264(1–2), 184–187 (2007).
   PubMed Web of Science ®Google Scholar
• Guadalupe-Grau A , Rodríguez-GonzálezFG, Ponce-GonzálezJGet al. Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS ONE5(7), e11529 (2010).
   PubMed Web of Science ®Google Scholar
• Rodríguez-González G , Ramírez-MorenoR, PérezPet al. The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women. J. Steroid Biochem. Mol. Biol.113(3–5), 202–208 (2009).
   PubMed Web of Science ®Google Scholar
• Rajender S , SinghL, ThangarajK. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J. Androl.9(2), 147–179 (2007).
   PubMed Web of Science ®Google Scholar
• La Spada A Spinal and bulbar muscular atrophy. In: GeneReviews™. PaganRA, AdamMP, AdringerHHet al. ( Eds). University of Washington, Seattle, WA, USA, 1993–2015 (1999). http://www.ncbi.nlm.nih.gov/books/NBK1333/.
   Google Scholar
• Igarashi S , TannoY, OnoderaOet al. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology42(12), 2300–2300 (1992).
   PubMed Web of Science ®Google Scholar
• Rhodes LE , FreemanBK, AuhSet al. Clinical features of spinal and bulbar muscular atrophy. Brain132(12), 3242–3251 (2009).
   PubMedGoogle Scholar
• Dejager S , Bry-GauillardH, BruckertEet al. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J. Clin. Endocrinol. Metabol.87(8), 3893–3901 (2002).
   PubMed Web of Science ®Google Scholar
• Jochum T , RitzME, SchusterCet al. Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures. Biochim. Biophy. Acta (BBA)1822(6), 1070–1078 (2012).
   PubMed Web of Science ®Google Scholar
• Davies P , WattK, KellySM, ClarkC, PriceNC, McEwanIJ. Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain. J. Mol. Endocrinol.41(5), 301–314 (2008).
   PubMed Web of Science ®Google Scholar
• Buchanan G , YangM, CheongAet al. Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum. Mol. Genet.13(16), 1677–1692 (2004).
   PubMed Web of Science ®Google Scholar
• Darnell G , OrgelJPRO, PahlR, MeredithSC. Flanking polyproline sequences inhibit β-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J. Mol. Biol.374(3), 688–704 (2007).
   PubMed Web of Science ®Google Scholar
• Kim MW , ChelliahY, KimSW, OtwinowskiZ, BezprozvannyI. Secondary structure of Huntingtin amino-terminal region. Structure17(9), 1205–1212 (2009).
   PubMed Web of Science ®Google Scholar
• Lakhani VV , DingF, DokholyanNV. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences. PLoS Comput. Biol.6(4), e1000772 (2010).
   PubMed Web of Science ®Google Scholar
• Jayaraman M , MishraR, KodaliRet al. Kinetically competing Huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry51(13), 2706–2716 (2012).
   PubMed Web of Science ®Google Scholar
• Fiumara F , FioritiL, KandelER, HendricksonWA. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell143(7), 1121–1135 (2010).
   PubMed Web of Science ®Google Scholar
• Adachi H , WazaM, TokuiKet al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J. Neurosci.27(19), 5115–5126 (2007).
   PubMed Web of Science ®Google Scholar
• Chevalier-Larsen ES , O'BrienCJ, WangHet al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci.24(20), 4778–4786 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt BJ , GreenbergCR, Allingham-HawkinsDJ, SpriggsEL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology59(5), 770–772 (2002).
   PubMed Web of Science ®Google Scholar
• Katsuno M , AdachiH, KumeAet al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron35(5), 843–854 (2002).
   PubMed Web of Science ®Google Scholar
• Katsuno M , AdachiH, DoyuMet al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med.9(6), 768–773 (2003).
   PubMed Web of Science ®Google Scholar
• Chevalier-Larsen ES , MerryDE. Testosterone treatment fails to accelerate disease in a transgenic mouse model of spinal and bulbar muscular atrophy. Dis. Model. Mech.5(1), 141–145 (2012).
   PubMed Web of Science ®Google Scholar
• Giorgetti E , RusminiP, CrippaVet al. Synergic prodegradative activity of bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum. Mol. Genet.24(1), 64–75 (2015).
   PubMed Web of Science ®Google Scholar
• Takeyama K , ItoS, YamamotoAet al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in drosophila. Neuron35(5), 855–864 (2002).
   PubMed Web of Science ®Google Scholar
• Nedelsky NB , PennutoM, SmithRBet al. Native functions of the androgen receptor are essential to pathogenesis in a drosophila model of spinobulbar muscular atrophy. Neuron67(6), 936–952 (2010).
   PubMed Web of Science ®Google Scholar
• Orr CR , MontieHL, LiuYet al. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J. Biol. Chem.285(46), 35567–35577 (2010).
   PubMed Web of Science ®Google Scholar
• LaFevre-Bernt MA , EllerbyLM. Kennedy's disease: phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death. J. Biol. Chem.278(37), 34918–34924 (2003).
   PubMed Web of Science ®Google Scholar
• Palazzolo I , BurnettBG, YoungJEet al. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum. Mol. Genet.16(13), 1593–1603 (2007).
   PubMed Web of Science ®Google Scholar
• Scaramuzzino C , CasciI, ParodiSet al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron85(1), 88–100 (2015).
   PubMed Web of Science ®Google Scholar
• Morfini G , PiginoG, SzebenyiG, YouY, PollemaS, BradyST. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci.9(7), 907–916 (2006).
   PubMed Web of Science ®Google Scholar
• Young JE , GardenGA, MartinezRAet al. Polyglutamine-expanded androgen receptor truncation fragments activate a bax-dependent apoptotic cascade mediated by DP5/Hrk. J. Neurosci.29(7), 1987–1997 (2009).
   PubMed Web of Science ®Google Scholar
• Minamiyama M , KatsunoM, AdachiHet al. Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat. Med.18(10), 1531–1538 (2012).
   PubMed Web of Science ®Google Scholar
• Montie HL , PestellRG, MerryDE. SIRT1 Modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. J. Neurosci.31(48), 17425–17436 (2011).
   PubMed Web of Science ®Google Scholar
• Mukherjee S , ThomasM, DadgarN, LiebermanAP, Iñiguez-LluhíJA. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J. Biol. Chem.284(32), 21296–21306 (2009).
   PubMed Web of Science ®Google Scholar
• Chua JP , ReddySL, YuZet al. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. J. Clin. Invest.125(2), 831–45 (2015).
   PubMed Web of Science ®Google Scholar
• Finsterer J . Perspectives of Kennedy's disease. J. Neurol. Sci.298(1–2), 1–10 (2010).
   PubMed Web of Science ®Google Scholar
• Cook T , SheridanWP. Development of GnRH antagonists for prostate cancer: new approaches to treatment. Oncologist5(2), 162–168 (2000).
   PubMedGoogle Scholar
• Shimohata T , KimuraT, NishizawaM, OnoderaO, TsujiS. Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin. J. Neurol. Neurosurg. Psychiatry75(8), 1206–1207 (2004).
   PubMed Web of Science ®Google Scholar
• Banno H , KatsunoM, SuzukiKet al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann. Neurol.65(2), 140–150 (2009).
   PubMed Web of Science ®Google Scholar
• Katsuno M , BannoH, SuzukiKet al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol.9(9), 875–884 (2010).
   PubMed Web of Science ®Google Scholar
• Fernández-Rhodes LE , KokkinisAD, WhiteMJet al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol.10(2), 140–147 (2011).
   PubMed Web of Science ®Google Scholar
• Wang AM , MiyataY, KlinedinstSet al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat. Chem. Biol.9(2), 112–118 (2013).
   PubMed Web of Science ®Google Scholar
• Rusmini P , SimoniniF, CrippaVet al. 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol. Dis.41(1), 83–95 (2011).
   PubMed Web of Science ®Google Scholar
• Khan SH , AhmadN, AhmadF, KumarR. Naturally occurring organic osmolytes: from cell physiology to disease prevention. IUBMB Life62(12), 891–895 (2010).
   PubMed Web of Science ®Google Scholar
• Tanaka M , MachidaY, NiuSet al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med.10(2), 148–154 (2004).
   PubMed Web of Science ®Google Scholar
• Street TO , KrukenbergKA, RosgenJ, BolenDW, AgardDA. Osmolyte-induced conformational changes in the Hsp90 molecular chaperone. Protein Sci.19(1), 57–65 (2010).
   PubMed Web of Science ®Google Scholar
• Kumar R . Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets. IUBMB Life64(11), 879–884 (2012).
   PubMed Web of Science ®Google Scholar
• Palazzolo I , NedelskyNB, AskewCEet al. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. J. Neurosci. Res.88(10), 2207–2216 (2010).
   PubMed Web of Science ®Google Scholar
• Miyazaki Y , AdachiH, KatsunoMet al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat. Med. Lett.18(7), 1136–1141 (2012).
   PubMed Web of Science ®Google Scholar
• Rinaldi C , BottLC, ChenKLet al. Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol. Med.18, 1261–1268 (2012).
   PubMed Web of Science ®Google Scholar
• Qiang Q , AdachiH, HuangZet al. Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease. J. Neurochem.126(1), 122–130 (2013).
   PubMed Web of Science ®Google Scholar
• Han TT , RanJ, DingXPet al. Cytogenetic and molecular analysis of infertile Chinese men: karyotypic abnormalities, Y-chromosome microdeletions, and CAG and GGN repeat polymorphisms in the androgen receptor gene. Genet. Mol. Res.8(12), 2215–2226 (2013).
   Google Scholar
• Lim HN , ChenH, McBrideSet al. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum. Mol. Genet.9(5), 829–834 (2000).
   PubMed Web of Science ®Google Scholar
• Rajender S , RajaniV, GuptaNJ, ChakravartyB, SinghL, ThangarajK. No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men. J. Androl.27(6), 785–789 (2006).
   PubMedGoogle Scholar
• Delli Muti N , AgarwalA, BuldreghiniEet al. Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia 46(5), 564–569 (2013).
   PubMed Web of Science ®Google Scholar
• Akinloye O , GromollJ, NieschlagE, SimoniM. Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men. J. Endocrinol. Invest.32(10), 797–804 (2009).
   PubMed Web of Science ®Google Scholar
• Lundin KB , GiwercmanYL, RylanderL, HagmarL, GiwercmanA. Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. Eur. J. Endocrinol.155(2), 347–354 (2006).
   PubMed Web of Science ®Google Scholar
• Komori S , KasumiH, KanazawaRet al. CAG repeat length in the androgen receptor gene of infertile Japanese males with oligozoospermia. Mol. Hum. Reprod.5(1), 14–16 (1999).
   PubMed Web of Science ®Google Scholar
• Radpour R , RezaeeM, TavasolyA, SolatiS, SalekiA. Association of long polyglycine tracts (GGN Repeats) in Exon 1 of the androgen receptor gene with cryptorchidism and penile hypospadias in iranian patients. J. Androl.28(1), 164–169 (2007).
   PubMedGoogle Scholar